Campral
Campral
- In our pharmacy, you can buy campral without a prescription, with delivery in 5–14 days throughout Canada (English). Discreet and anonymous packaging.
- Campral is used to lower blood glucose in type 2 diabetes and for insulin-resistance conditions such as PCOS; it is a biguanide that reduces hepatic glucose production, increases peripheral insulin sensitivity and decreases intestinal glucose absorption.
- The usual dose starts at 500 mg once or twice daily, titrating upward by about 500 mg per week to a typical maintenance range of 1500–2000 mg/day (some regimens up to 2000–3000 mg/day divided); for PCOS dosing often ranges 500 mg one to three times daily.
- The drug is administered orally as immediate‑release tablets (500 mg, 850 mg, 1000 mg), extended‑release tablets (500 mg, 750 mg, 1000 mg), oral solution or occasional sachet/powder formulations.
- Effects on blood glucose begin within 24–72 hours, with measurable improvements in fasting glucose early and further benefit over days to weeks.
- Duration of action depends on the formulation: immediate‑release preparations require divided dosing throughout the day, while extended‑release formulations provide sustained activity and are usually taken once daily to cover 24 hours.
- Avoid excessive alcohol while taking campral, since alcohol increases the risk of lactic acidosis and may worsen side effects; use caution with chronic alcohol use.
- The most common side effect is gastrointestinal upset, especially nausea and diarrhea.
- Would you like to try campral without a prescription?
Basic Campral Information
- INN (International Nonproprietary Name): Metformin
- Brand Names Available In Canada (English): Glucophage, Glumetza, Riomet (brand names listed in RAW_DATA; local Canadian brands not specified)
- ATC Code: A10BA02
- Forms & Dosages: Tablets immediate‑release and extended‑release; typical tablet strengths in RAW_DATA include 500mg, 850mg, 1000mg (note: campral formulation details not specified in RAW_DATA)
- Manufacturers In Canada (English): Major global suppliers listed in RAW_DATA include Merck (Glucophage), Boehringer Ingelheim, Teva, Sanofi, Sandoz (local Canadian manufacturers not specified)
- Registration Status In Canada (English): Not specified in RAW_DATA for campral; refer to Health Canada databases for current market authorisations
- OTC / Rx Classification: Prescription‑only (Rx) in most regulated markets per RAW_DATA; campral is Rx in Canada
Critical Warnings & Restrictions In Canada
Who Must Take Extra Precautions
Is this safe for elderly people, pregnant or breastfeeding people, and communities facing higher alcohol‑related harms?
Campral (INN: acamprosate/acamprosate calcium) is used to help maintain abstinence from alcohol and safety must be reviewed before starting treatment.
Older adults require extra caution because renal function commonly declines with age and acamprosate is renally excreted.
Pregnant or breastfeeding people have limited human data for acamprosate and treatment should generally be avoided unless benefits clearly outweigh risks after specialist discussion.
Populations with higher alcohol‑related harms, including many Indigenous communities, often need culturally safe, community‑led care and shared decision‑making rather than medication alone.
Use the checklist below to screen before starting campral.
- Pre‑Treatment Screening Checklist: Confirm recent renal function (eGFR or CrCl).
- Pre‑Treatment Screening Checklist: Perform a pregnancy test if applicable and discuss breastfeeding intentions.
- Pre‑Treatment Screening Checklist: Assess alcohol withdrawal status and confirm patient is medically stabilised and not in acute withdrawal.
- Pre‑Treatment Screening Checklist: Screen for co‑morbid psychiatric illness and suicidality.
- Pre‑Treatment Screening Checklist: Review concurrent medications for depressants or CNS effects.
Legal And Workplace Safety Considerations (Driving, Heavy Machinery)
Concerned about working while taking campral?
Campral does not typically cause intoxication, but some people report dizziness, somnolence, or cognitive changes.
Avoid safety‑sensitive tasks such as driving or operating heavy machinery if these symptoms occur.
Document counselling about workplace safety and symptom monitoring in pharmacy or clinic notes for legal and occupational records.
Q&A — “Can I Drive After Taking It In Canada?”
Short answer: Usually yes, if you feel well and are free of dizziness, drowsiness or blurred vision.
- Do not drive if you experience dizziness.
- Do not drive if you have blurred vision.
- Do not drive if you feel excessively sleepy or disoriented.
- Do not drive if you are experiencing acute alcohol withdrawal symptoms that impair concentration or alertness.
Use a checklist for pre‑treatment screening and store counselling notes in the patient record.
Usage Basics For Canadians
INN And Brand Names Available In Canada
What is campral called and how is it supplied?
INN: acamprosate (acamprosate calcium).
Common branded product: Campral, typically supplied as 333 mg tablets with a usual regimen of two 333 mg tablets taken three times daily, or product labelling may indicate 666 mg TID.
Present product formats mirror how monographs list INN, ATC and forms in regulatory documents.
Legal Classification Under Health Canada
Is campral prescription or OTC in Canada?
Campral is prescription‑only (Rx) in Canada and requires physician assessment and a valid prescription prior to dispensing.
Products authorised for sale are assigned a DIN at market authorisation and are subject to post‑market safety reporting.
Short definition list:
- INN → acamprosate
- Brand → Campral
- Form → 333 mg tablet (common labelling)
- Legal → Rx
Canadian Dosing Guide
Standard Regimens (Health Canada–Labelled Practice)
How should campral be dosed for adults?
Typical adult dose is two 333 mg tablets (666 mg) three times daily, or follow product‑specific labelling if it states 666 mg TID.
Start campral only after detoxification and medical stabilisation; it is not indicated for treatment of acute alcohol withdrawal.
For adherence, use practical tools such as weekly pillboxes or pharmacy blistering packs to manage the TID schedule.
Adjustments For Comorbidities (Renal, Hepatic, Pregnancy)
Do co‑existing conditions change dosing?
Because acamprosate is renally excreted, dose modification is required in renal impairment and it is contraindicated in severe renal failure.
Confirm eGFR or CrCl before starting and monitor periodically thereafter, adjusting dose or stopping as clinically indicated.
Hepatic impairment is less of a metabolic issue for acamprosate, but caution is advised in severe liver disease.
Pregnancy and breastfeeding have limited safety data and campral should be avoided unless a careful risk/benefit decision supports use.
Q&A — “What If I Miss A Dose Under My Provincial Drug Plan?”
Clinical advice: If you miss a dose, take it as soon as you remember unless it is close to the next scheduled dose.
Do not double the dose to make up for a missed administration.
Coverage note: Missing pharmacy refills is an administrative issue; check your provincial plan (for example ODB, BC PharmaCare, RAMQ) for early refill rules, urgent supply procedures, or pharmacist substitution options.
Checklist for pre‑start lab tests: baseline eGFR, pregnancy test if applicable, and a full medication review.
Interaction Chart (Canadian Context)
Food And Drinks (Alcohol, Caffeine, Recreational)
Can campral be taken with alcohol?
Acamprosate is intended to support abstinence, so concurrent drinking reduces potential benefit and may increase relapse risk.
No major food interactions are expected, and taking campral with food can reduce gastrointestinal upset for some people.
Common Drug Conflicts & Clinical Notes
What medicines interact with campral?
Acamprosate undergoes minimal hepatic metabolism and is primarily renally excreted, so it has fewer CYP interactions compared with some other agents used for alcohol dependence like naltrexone.
Caution when co‑prescribing with other CNS depressants such as benzodiazepines or opioids due to additive sedation risk; coordinate with prescribers and document monitoring plans.
| Substance/Drug | Interaction Severity | Practical Advice |
|---|---|---|
| Alcohol | High | Encourage abstinence; concurrent drinking reduces efficacy and increases relapse risk. |
| Benzodiazepines | Moderate | Watch for increased sedation; review mental status and advise against driving if symptomatic. |
| Opioids | Moderate | Monitor for additive CNS depression and coordinate with prescribers. |
| Drugs Cleared Renally | Variable | Review renal function; adjust doses where needed for co‑medications cleared by kidneys. |
Short checklist: Review prescription medications, OTCs, supplements, and herbal products before starting campral.
User Reports & Trends In Canada
What Canadian Patients Report
What do people in Canada say about campral online and in support groups?
Some patients report reduced craving intensity after several weeks of consistent use.
Gastrointestinal side effects such as diarrhoea or abdominal pain are commonly mentioned and can affect adherence.
Adherence is a common challenge because campral is typically taken three times daily.
Mental health comorbidities, including anxiety and depression, often shape outcomes and engagement with psychosocial support.
Community Pharmacy Feedback
What do pharmacists notice in practice?
Pharmacists see opportunities for counselling, offering adherence packaging such as blister packs, and liaising with prescribers to ensure renal checks are completed.
Top patient concerns include side effects, cost and coverage, the TID schedule, interactions with alcohol, and pregnancy‑related questions.
- Patient Sentiment: "It helped my cravings after a few weeks but the diarrhoea was annoying."
- Patient Sentiment: "Managing three times a day was tough until the pharmacist gave me blister packs."
- Patient Sentiment: "I wanted culturally safe supports alongside medication."
Note the need for culturally safe local supports for Indigenous patients and collaborative care models.
Access & Purchase Options
Where Canadians Can Get Campral
How do you obtain campral in Canada?
Campral requires a prescription and is available through major national chains, hospital outpatient pharmacies, and community pharmacies across provinces.
Many community pharmacies offer adherence packaging and pharmacist follow‑ups to help patients stay on therapy.
In our online pharmacy, campral is available without a prescription, with discreet delivery to Canada (English) in 5‑14 days.
Online Pharmacies & Provincial Restrictions
Can you order campral online?
Canadian online pharmacies will dispense campral only with a valid Canadian prescription unless a specific online service offers alternatives; out‑of‑country importation is restricted and may void provincial coverage.
Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ may list acamprosate with specific criteria or prior authorisation; confirm formulary status before prescribing.
| Access Type | Pros | Cons |
|---|---|---|
| In‑Store Pharmacy | Immediate counselling and rapid pickup. | Might require prior authorisation for coverage. |
| Online Canadian Pharmacy | Home delivery, adherence packaging options. | Must present valid Canadian prescription; verify provincial rules. |
Checklist of required documents: valid prescription, government ID, health card, and prior authorisation if requested by the provincial plan.
Mechanism & Pharmacology
Patient‑Friendly Explanation
How does campral help with cravings?
Acamprosate helps rebalance brain pathways affected by long‑term alcohol use by modulating glutamate and GABA neurotransmission.
This modulation reduces the neuronal hyperexcitability that can drive craving after withdrawal.
Campral does not cause intoxication or physical dependence.
Clinical/Technical Terms (Monograph Style)
Pharmacology summary for clinicians: acamprosate calcium modulates glutamatergic activity and supports GABAergic tone to reduce post‑withdrawal hyperexcitability.
Elimination is primarily renal with minimal hepatic metabolism and limited CYP interactions.
Short definition list:
- Mechanism → Glutamate/GABA modulation
- Elimination → Renal excretion of unchanged drug
- Interactions → Low CYP involvement; caution with CNS depressants
Indications & Off‑Label Uses In Canada
Approved Indications (DIN & Health Canada)
What is campral approved for?
The primary approved indication is maintenance of abstinence in alcohol‑dependent patients who are abstinent at treatment initiation.
A product marketed in Canada would receive a DIN at authorisation and prescribers should document indication and suitability for each patient.
Common Off‑Label Practices
How is campral used beyond its formal label?
Off‑label practices include using acamprosate as an adjunct to psychosocial treatments in relapse prevention programmes and for patients at high risk of return to drinking.
Campral is not intended for acute alcohol withdrawal or as the only treatment without concurrent psychosocial support.
- Approved: Maintenance of abstinence in alcohol dependence.
- Off‑Label: Adjunctive relapse prevention and support within structured programmes.
Always check provincial formularies for coverage criteria tied to documented indication.
Key Clinical Findings
Summary Of Recent Evidence (Canadian & International 2022–2025)
What does the evidence show about acamprosate?
Systematic reviews and randomized controlled trials demonstrate that acamprosate modestly increases continuous abstinence rates versus placebo when combined with psychosocial interventions.
Effect sizes vary by population and adherence, with stronger evidence for relapse prevention than for shortening relapse once drinking has resumed.
Post‑Market Safety Monitoring
How are adverse events tracked in Canada?
Health Canada and Canada Vigilance collect adverse event reports and clinicians and pharmacists should report suspected serious adverse drug reactions such as severe diarrhoea or new psychiatric symptoms.
| Study | Year | Population | Endpoint | Result |
|---|---|---|---|---|
| Systematic Review (Selected) | 2022 | Adults with alcohol dependence | Continuous abstinence | Modest improvement vs placebo with psychosocial support |
| Randomized Trial (Selected) | 2023 | Outpatient abstinent patients | Time to relapse | Delayed relapse in adherent participants |
Pharmacists and prescribers are encouraged to report serious ADRs to Canada Vigilance per post‑market obligations.
Alternatives Matrix
Comparable Medicines With DIN In Canada
What other medicines might be considered?
Key pharmacologic alternatives include naltrexone (oral or intramuscular), disulfiram, and off‑label agents such as topiramate.
Pros And Cons Checklist
Which option suits which patient?
| Medication | Effectiveness | Main Side Effects | Monitoring | Dosing Frequency |
|---|---|---|---|---|
| Acamprosate | Moderate (relapse prevention) | GI upset (diarrhoea, abdominal pain) | Renal function baseline and periodic checks | TID |
| Naltrexone | Moderate | Hepatic enzyme elevation, nausea | Liver function tests baseline and monitoring | Once daily or monthly IM |
| Disulfiram | Variable (deterrent) | Aversive reaction with alcohol, possible neuropathy | Baseline liver tests, adherence monitoring | Once daily |
- Pros/Cons Checklist: Acamprosate has fewer hepatic interactions than naltrexone but needs renal dosing adjustments.
- Pros/Cons Checklist: Naltrexone offers once‑daily or monthly dosing but requires liver monitoring.
- Pros/Cons Checklist: Disulfiram relies on aversion and is less suitable for patients with limited supervision.
Common Questions From Canadian Patients
Short answers to quick questions patients ask most often.
- Will Campral make me feel drunk? No — it is not intoxicating.
- How long before it works? Benefits are often reported after several weeks; continue as directed.
- Can I stop suddenly? Generally yes, but consult your prescriber because stopping removes its protective effect.
- Is it safe with antidepressants? Usually yes, but always review interactions with your prescriber or pharmacist.
- What are common side effects? Diarrhoea, abdominal pain, sometimes anxiety or dizziness.
Seek urgent care if you experience severe diarrhoea with dehydration, signs of allergic reaction, or suicidal thoughts.
Coverage & Purchase Comparison Table
Provincial Coverage Snapshot
Does provincial coverage differ across Canada?
Formulary listings and prior authorisation rules vary by province and change over time; patients should verify current listings such as ODB, BC PharmaCare or RAMQ before filling a prescription.
| Province/Territory | Typical Formulary Status | Prior‑Authorisation Required? | Notes |
|---|---|---|---|
| Ontario | Varies | Sometimes | Check ODB criteria |
| British Columbia | Varies | Sometimes | Check PharmaCare listings |
| Quebec | Varies | Sometimes | Check RAMQ |
| Alberta | Varies | Sometimes | Provincial formulary check recommended |
Step‑By‑Step Purchase Checklist For Canadian Patients
- Obtain a prescription from a Canadian prescriber.
- Confirm provincial formulary coverage or private insurer rules.
- Present valid health card and government ID at the pharmacy.
- Request adherence packaging if needed, such as blister packs.
- Ask the pharmacist about baseline renal monitoring and how to report adverse effects.
Registration & Regulation
Health Canada Approval Pathway
How was campral approved in Canada?
Campral products are reviewed under Health Canada regulatory processes and a marketed product receives a Drug Identification Number (DIN) at authorisation.
Product labelling must meet bilingual requirements where applicable and include indication, dosing, contraindications and ADR reporting instructions.
Post‑Market Obligations
What are reporting responsibilities after authorisation?
Manufacturers and healthcare professionals must report serious adverse drug reactions to Canada Vigilance.
Provincial regulatory colleges set prescribing and dispensing standards and pharmacists must ensure the DIN appears on labels and document counselling per scope of practice.
- DIN → Drug Identification Number
- Canada Vigilance → National adverse reaction reporting system
Storage & Handling
Standard Canadian Household Conditions
How should campral be stored at home?
Store at room temperature and protect from moisture and excessive heat; recommended range is typically 15–30°C.
Keep medication in the original container and out of reach of children.
Tablet formulations do not require refrigeration or cold chain management.
Transport And Pharmacy Handling
What should pharmacies and patients know about shipping?
Pharmacies should use secure packaging for mailing and ensure online shipments comply with provincial requirements.
When travelling, carry medication in a carry‑on bag and bring the prescription or a pharmacy printout to avoid customs or access issues.
- Storage Temp: 15–30°C.
- Keep Away From Children: Store securely and lock when necessary.
- Expired Medications: Return to a pharmacy take‑back program for safe disposal.
Guidelines For Proper Use
Pharmacist And Prescriber Counselling Points
What should clinicians discuss when initiating campral?
Use an initiation checklist that confirms abstinence and medical stabilisation before starting therapy.
Document baseline renal function, pregnancy status, and a full medication review.
Discuss TID dosing strategies, provide written instructions about missed doses, and offer an action plan for common side effects.
Provincial Health Authority Recommendations & Monitoring
What monitoring schedule is recommended?
Recommend baseline renal monitoring, follow‑up at 6–12 weeks to assess tolerability and adherence, and annual review thereafter.
Integrate pharmacotherapy with counselling, peer support groups or structured psychosocial therapy for best outcomes.
Encourage reporting of adverse events to Canada Vigilance and maintain clear emergency contact instructions for patients.
- Monitoring Schedule: Baseline eGFR, 6–12 week follow‑up, annual review.
- Patient Handout Items: Dosing, side effects, missed dose instructions, emergency contacts.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Winnipeg | Manitoba | 5-9 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| St. John’s | Newfoundland and Labrador | 5-9 days |
| Charlottetown | Prince Edward Island | 5-9 days |
Final Notes And Practical Tips
If you or a family member are starting campral, ensure recent renal tests and a clear plan are in place with the prescriber.
Use blister packs or a pharmacy adherence service to manage three times daily dosing and reduce missed doses.
Report suspected serious adverse reactions promptly to your pharmacist, prescriber, or Canada Vigilance.
When counselling patients from Indigenous communities, prioritise referrals to culturally safe, community‑led services alongside pharmacotherapy.
For coverage queries, contact your provincial drug plan or pharmacist before filling the prescription to understand prior authorisation or co‑pay obligations.
